(Total Views: 360)
Posted On: 01/08/2020 11:58:57 AM
Post# of 154896
Hate to be the downer regarding this article, but it's so riddled with typos and errors that any serious investors who start to look into it would doubt the claims. Just a few examples:
- Talking about CTC's without ever mentioning cancer.
- Mixing up BTD and BLA.
- Expecting revenue in June 2019.
The message is absolutely spot on in my opinion, and I don't disagree with the valuation. But poorly written articles aren't going to help the cause in the real world with investors who have real money to put in. I wish the author would have been more careful so the (excellent) point doesn't risk being lost upon hasty examination.
- Talking about CTC's without ever mentioning cancer.
- Mixing up BTD and BLA.
- Expecting revenue in June 2019.
The message is absolutely spot on in my opinion, and I don't disagree with the valuation. But poorly written articles aren't going to help the cause in the real world with investors who have real money to put in. I wish the author would have been more careful so the (excellent) point doesn't risk being lost upon hasty examination.
(1)
(0)
